Search
Back

Zanubrutinib

CAS 1691249-45-2
Zanubrutinib

General Information

Zanubrutinib is a small molecule inhibitor of Bruton tyrosine kinase, with more selectivity compared with approved agents in its class, like ibrutinib.


About the API

Technology Synthetic
Therapeutic category Oncology
Available formulations Oral Solid Long-Acting
Regulations
  • Japan DMF
  • Korea DMF
  • US DMF

The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.

For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.